James PalacinoVice President and Head of Biology at Orum TherapeuticsSpeaker
Profile
James Palacino has nearly 20 years of oncology drug discovery and development experience in both pharma (Novartis Institutes for Biomedical Research) and biotech (H3 Biomedicine and currently as VP & Head of Biology at Orum Therapeutics). His R&D expertise includes both small molecule and antibody-drug-conjugate therapeutic modalities. He has led projects at stages from early discovery, through translational research, through candidate selection, IND-enabling and submissions, and partnered with clinical development for Phase 1/2 trials.
Agenda Sessions
Development of TPD2, A Dual-precision Approach for Targeted Delivery of Targeted Protein Degraders
, 9:15amView Session